FDA
-
-
-
-
-
-
-
Rapport Therapeutics partners with Tenacia for RAP-219 in greater china
-
-
-
-
-
-
-
Rapport Therapeutics to present RAP-219 epilepsy data at AES meeting
-
-
-
-
-
-
-
Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate Updates
-
-
-
-
-
-
-
CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders
-
-
-
-
-
-
-
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update
-
327,799 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

